Nicola Mendelsohn, an accomplished advertising industry executive who leads Facebook in Europe. Lynn O’Connor Vos, a pediatric-nurse-turned-communications guru. Michael Milken, a financier with a penchant for philanthropy. What do they have in common? They’re leading progress towards curing very specific diseases: follicular lymphoma, muscular dystrophy, and prostate cancer.